Vifor AG, a prominent player in the pharmaceutical industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 2000, the company has established itself as a leader in iron deficiency and nephrology, focusing on innovative therapies that address critical health needs. Vifor AG's core products include iron replacement therapies and treatments for chronic kidney disease, distinguished by their commitment to patient-centric solutions and high-quality standards. The company has achieved significant milestones, including strategic partnerships and a robust pipeline of products that enhance its market position. With a strong emphasis on research and development, Vifor AG continues to make notable contributions to the healthcare landscape, solidifying its reputation as a trusted provider of specialised medical solutions.
We don't have data for Vifor AG, but we can show you information about their parent organization instead.
View parent company